NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

CRITICAL APPRAISAL ON AN ARTICLE ABOUT PROGNOSIS
Is Radical Prostatectomy Adequate For High Risk Prostate Cancer?
National Prostate Cancer Audit Julie Nossiter, Project Manager Clinical Effectiveness Unit – Royal College of Surgeons.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Advanced Stage Prostate Cancer Management Michael E. Karellas Assistant Professor of Urologic Oncology May 15, 2010.
National Prostate Cancer Audit Heather Payne, NPCA Oncological Clinical Lead Consultant Clinical Oncologist, UCL.
Neoadjuvant Chemotherapy in Malignant Peripheral Nerve Sheath Tumors Elizabeth Shurell, M.D., M.Phil. UCLA General Surgery Resident Research Fellow, Division.
The PRIAS Study In Australia One Institution’s Experience Introduction PRIAS (Prostate cancer Research International: Active Surveillance – NTR1718) is.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
EXTRAPERITONEAL RADICAL PROSTATECTOMY AND PREVIOUS HISTORY OF HERNIA REPAIR: EVALUATION OF RESULTS SELCUK KESKIN, GUILLAUME GUICHARD, ÁNDRAS HOZNEK, ALEXANDRE.
Sentinel Lymph Node Biopsy in Melanoma
59 years old man Hx of stomach adenocarcinoma 20 years ago Hx of chemoradiotherapy cc:gross hematuria.
Radical Prostatectomy: A Critical Analysis of Surgical Quality Between the Open and Laparoscopic Approaches. Karim Touijer, MD.
Mr Jonathan Lewin MBBS, MRCS, MD, FRCS(Urol), FRACS Consultant Uro-Oncological Surgeon.
Radical Prostatectomy Sept 2009 till Aug 2010 South Mersey Cancer Network Manal Kumar Consultant Urologist.
Steven Joniau Filip Ameye
PROSTATE CANCER LETS DEBATE !!!! Dr Fred C Tyler MBChB FRCS FCS UROL.
PROGRESS IN MANAGEMENT OF PROSTATE CANCER Presented by Dr. J. Nkusi on the October 2007, 38 th Congress of the Botswana Medical Association.
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
Treatment options for locally recurrent Prostate Cancer Giuseppe Simone Mediterranean School of Oncology Roma
Modern Management of Prostate Cancer With Active Surveillance PROSTATE CANCER SYMPOSIUM NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE SEPTEMBER 10,
How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014.
Surgical Management of Urothelial Carcinoma A 21 st Century Approach Douglas S. Scherr, M.D. Clinical Director, Urologic Oncology Weill Medical College.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Prostate Cancer Treatment: What’s Best For You?
Laparoscopic Radical Prostatectomy: Oncological and Functional Outcomes Following Fellowship Training. Introduction Radical Prostatectomy (RP) is a technically.
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
Lymphadenectomy in the surgical treatment of prostate cancer - does it influence survival? Oliver Hakenberg Urologische Klinik und Poliklinik Universitätsklinikum.
Poster Title ABSTRACT #59 Cell cycle progression genes differentiate indolent from aggressive prostate cancer. Steven Stone 1 Jack Cuzick 2, Julia Reid.
Oncology 11 Localised Prostate Cancer VIVA
Minimally Invasive Approaches in the Treatment of Urothelial Carcinoma “Robotic Radical Cystectomy” Douglas S. Scherr, M.D. Weill Medical College of Cornell.
J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.
Role of Sentinel Lymph Node Biopsy in the Staging of Synovial, Epithelioid, and Clear Cell Sarcomas. Ugwuji N. Maduekwe, Francis J. Hornicek, Dempsey S.
South West Public Health Observatory South West Regional Public Health Group Prostate cancer in England and the South West Sean McPhail 1, Paul Eves 1,
Trends in prostate cancer and its management in the South West Region, Hampshire and the Isle of Wight Christine Harling Julia Verne (SWPHO) Roy Maxwell.
South West Public Health Observatory The changing casemix of prostate cancer patients and prostatectomies in the South West Sean McPhail.
Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Postsurgical Risk Factors for Prostate Cancer Mortality Slideset on: Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer–specific mortality.
Robot-assisted Laparoscopic Radical Cystectomy KH Rha Severance Hospital Yonsei University The 10 th Catholic International Urology Symposium, :30–14:50.
NPCR Data Completeness and Quality Audits Review of: Collaborative Stage and Surgery Data Mary Lewis, CTR NPCR Program Consultant.
IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC.
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.
Robotic-assisted Laparoscopic Prostatectomy
Per-Anders Abrahamsson Department of Urology Malmö University Hospital
Surgical Treatment in Locally Advanced Prostate Cancer
Fig. 3. Kaplan-Meier analyses of biochemical recurrence (BCR)-free survival rates according to ADCmeanvalues among the total subjects (A) and among the.
Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.
Nat. Rev. Urol. doi: /nrurol
New perioperative risk factors for biochemical recurrence after robotic assisted radical prostatectomy: A single surgeon experience in high volume Canadian.
The Role of Radical Prostatectomy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer: A Systematic Review and Meta-Analysis Urol Int 2017;99:
RELAZIONE TRA “STAGE MIGRATION” E
Post Op Positive Seminal Vesicle Case 4: Prostate_4
Prostate Cancer: Highlights from 2006
Volume 49, Issue 2, Pages (February 2006)
Development and internal-external validation of a multivariable prediction model for pre-operative assessment of positive lymph nodes during robot assisted.
ROBOTIC ASSISSTED RADICAL PROSTATECTOMY OUR INITIAL EXPERIENCE
Apollo Gleneagles Hospitals,
Volume 46, Issue 3, Pages (September 2004)
What is New in Hormone Therapy for Prostate Cancer in 2007?
Volume 64, Issue 5, Pages (November 2013)
Thromboembolic Events Following Surgery for Prostate Cancer
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Patients who have received chemotherapy (n=60)
Volume 53, Issue 5, Pages (May 2008)
Management of Prostate Cancer: Global Strategies
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Surgery for high-risk prostate cancer: The results of first 80 cases
Presentation transcript:

NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator Senior Lecturer in Genitourinary Oncology Consultant Urological Surgeon, UCL & Barts

Surgeons perspective

The classic patient presenting in the clinic 62 year old chap Well man clinic – offered a PSA test Often asymptomatic Returns mildly elevated – 5.3 Referred to his local urologist

6

7

Prostate biopsy

Patient assigned a Gleason grade for his tumour and a clinical stage Gleason score 6-10 (3+3, 3+4, 4+3, 4+4, 4+5, 5+4, 5+5)

Surgical Treatment

11

Outcome of surgery

Minimum Dataset 2

Data Items Data item 1 – organisation site code CR1450 – The hospital identifier code Data item 2 - consultant code (treatment) CR0660 – Code of the consultant (derived from GMC code) that is responsible for the treatment of the patient No provision in COSD at present to document the surgeon who performs the procedure – NPCA will report surgeon level data on the basis of CR0660

Data Items Type of radical prostatectomy – Open – Robotic – Laparoscopic – Not known

Data Items Procedure nerve sparing – (bilateral, unilateral, none)

Data Items T category (pathological) N category (pathological) – Presence of tumour within regional Lymph nodal tissue

Data Items Clinical stage differs from pathological stage Up to 1/3 of men may be upstaged to T3 disease after surgery

Data Items Organ confined (Yes/No) – Aids completeness of staging – T2 – organ confined – T3 – locally advanced Seminal vesicle invasion

Data Items Radical prostatectomy margin status – Negative margins – Positive margins less than 3mm – Positive margins greater than or equal to 3 mm – Positive margin, length unknown Sooriakumaran P, Ploumidis A, Nyberg T, Olsson M, Akre O, Haendler L, Egevad L, Nilsson A, Carlsson S, Jonsson M, Adding C, Hosseini A, Steineck G, Wiklund P. The impact of length and location of positive margins in predicting biochemical recurrence after robotic-assisted radical prostatectomy with a minimum follow-up time of five years. BJU Int Oct 4.The impact of length and location of positive margins in predicting biochemical recurrence after robotic-assisted radical prostatectomy with a minimum follow-up time of five years.

Data Items Lymphadenectomy (Yes/No) Change to data item – Used to have number of positive nodes and number of nodes removed

Rationale for change in data item 174 patients who underwent PLND at two different hospitals PLND was performed according to a standardized template Mean number of reported lymph nodes was 16 at hospital A versus 28 at hospital B Overall survival (OS), disease-specific survival (DSS) and recurrence-free survival (RFS) were the same Pathological reporting markedly influences nodal yield The data item was therefore not felt reliable for national use Mertens LS, Meijer RP, van Werkhoven E, Bex A, van der Poel HG, van Rhijn BW, Meinhardt W, Horenblas S Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival.World J Urol Oct;31(5): Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival.

Thank You